Cano Health, Inc.
NYSE:CANO
2.3 (USD) • At close February 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||
Net Income
| -491.697 | -270.745 | -60.585 | -301.729 | -112.011 | -14.564 | -0.085 | -70.334 | -40.88 | 4.947 | -10.47 | -46.775 | -11.117 | -10.986 |
Depreciation & Amortization
| 26.74 | 27.252 | 27.221 | 26.425 | 25.343 | 19.836 | 19.036 | 18.695 | 16.955 | 7.945 | 5.846 | 5.758 | 5.379 | 3.977 |
Deferred Income Tax
| 350.102 | -1.872 | 0 | 0 | 0 | 0.809 | 0 | -58.459 | 0.547 | -2.023 | 0 | 30.597 | 5.669 | -0.019 |
Stock Based Compensation
| -4.083 | 2.017 | 9.351 | 12.822 | 13.235 | 17.784 | 13.816 | 15.835 | 8.909 | 3.168 | 0.071 | 0.351 | 0.065 | 0.057 |
Change In Working Capital
| 58.158 | 164.804 | -3.33 | -45.287 | -1.07 | -34.846 | -42.028 | 66.864 | -29.724 | -35.817 | -14.609 | 18.947 | -9.47 | 0 |
Accounts Receivables
| 19.665 | 135.058 | -8.406 | -30.83 | -8.356 | -9.266 | -58.291 | 80.856 | -41.018 | -43.74 | -11.233 | 2.977 | -15.48 | 0 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.671 | -0.602 | -0.153 | -0.101 | 0.209 | -0.211 | 0 |
Change In Accounts Payables
| 18.02 | 16.746 | 11.543 | 1.657 | 40.317 | -19.372 | 10.01 | -11.973 | 10.941 | 7.135 | 4.034 | 10.217 | 5.917 | 0 |
Other Working Capital
| 20.473 | 13 | -3.137 | -16.114 | -33.031 | -6.208 | 6.253 | -2.69 | 0.955 | 0.941 | -7.309 | 5.544 | 0.304 | 0 |
Other Non Cash Items
| 21.069 | 63.059 | -2.127 | 245.59 | 72.518 | -33.989 | -27.942 | -9.63 | 9.275 | -18.093 | 2.455 | 2.93 | 1.574 | 6.971 |
Operating Cash Flow
| -39.711 | -15.485 | -29.47 | -62.179 | -1.985 | -44.97 | -37.203 | -37.029 | -34.918 | -39.873 | -16.707 | 11.808 | -7.9 | -6.971 |
Investing Activities: | ||||||||||||||
Investments In Property Plant And Equipment
| -6.869 | -6.19 | -5.08 | -10.468 | -18.63 | -12.655 | -7.776 | -11.133 | -15.491 | -5.085 | -2.645 | -2.63 | -5.471 | 0 |
Acquisitions Net
| 0 | 0 | 0 | -0.801 | 0 | -1.5 | -3.495 | -1.646 | -451.085 | -616.678 | -0.898 | -2.3 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 33.416 | -2.052 | -4.379 | -4.733 | -0.25 | -1.661 | -2.186 | -2.439 | -0.185 | -17.807 | -6.156 | -9.882 | -2.157 | 0 |
Investing Cash Flow
| 26.547 | -8.242 | -9.459 | -16.002 | -18.88 | -15.816 | -13.457 | -15.218 | -466.761 | -639.57 | -9.699 | -14.812 | -7.628 | 0 |
Financing Activities: | ||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 26.774 | 6.56 | 56.488 | 81.413 | -2.885 | -4.419 | 0.542 | 6.504 | 391.315 | 992.475 | -2.818 | 9.388 | 32.235 | 0 |
Financing Cash Flow
| 26.774 | 6.56 | 56.488 | 81.413 | -2.885 | -4.419 | 0.542 | 6.504 | 391.315 | 992.118 | -0.799 | 9.388 | 32.235 | 0 |
Other Information: | ||||||||||||||
Effect Of Forex Changes On Cash
| 0 | -226.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 13.61 | -17.167 | 17.559 | 3.232 | -23.75 | -65.205 | -50.118 | -45.743 | -110.364 | 312.675 | -27.205 | 6.384 | 16.707 | -6.971 |
Cash At End Of Period
| 41.331 | 27.721 | 44.888 | 27.329 | 24.097 | 47.847 | 113.052 | 163.17 | 208.913 | 319.277 | 6.602 | 33.807 | 27.423 | -6.971 |